IWA
XBI icon

Icon Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Icon Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,501
Closed -$142K – 501
2024
Q1 		$142K Hold
1,501
– – 0.01% 397
2023
Q4 		$134K Buy
+1,501
New +$111K 0.01% 380
2022
Q4 		$535K Sell
6,444
-3,750
-37% -$304K 0.06% 185
2022
Q3 		$809K Buy
+10,194
New +$859K 0.1% 149

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Icon Wealth Advisors's XBI Position: Q2 2024 in Review

Icon Wealth Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 1,501 shares — an estimated $142K sold.

Icon Wealth Advisors first reported a position in XBI in Q3 2022 and held it in 4 quarters. The position peaked at $809K in Q3 2022. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • Icon Wealth Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • Icon Wealth Advisors sold 1,501 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $142K.
  • Icon Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 4 quarters.
  • Icon Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $809K in Q3 2022.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Icon Wealth Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.